We will talk about BIOVIA’s Generative Therapeutics Design (GTD) and integration of NVIDIA’s MolMIM generative AI to accelerate small molecule drug discovery.
Join us on BIOVIA’s Generative Therapeutics Design (GTD), featuring the integration of NVIDIA’s MolMIM generative AI to accelerate small-molecule drug discovery. Learn how to explore chemical space, perform AI-driven virtual screening, and optimize candidates using structure-based modeling.
Discover how GTD enables multi-parameter optimization across key factors such as docking, pharmacophore features, ADME, pharmacokinetics, pharmacodynamics, and bioavailability—helping you design better drug candidates, faster.
